Virpax Pharmaceuticals (VRPX): Net earnings per share for the last 12 months

Symbol and logo of brand virpaxpharma.com (VRPX)

Virpax Pharmaceuticals (VRPX) is developing a non-opioid pain management environment, although the FDA and courts are constraining growth. Net income per share over the last 12 months on this chart on GURU.Markets shows that the current value is -70.73. The company creates smart mucosal drug delivery systems, generating revenue by supplying safe opioid alternatives for hospitals and military physicians.

VRPX (Virpax) Net earnings per share for the last 12 months history from 07/04/2022 to 04/13/2025

Analytical breakdowns and data insights for company virpaxpharma.com (VRPX)

- current quotes and average value forecast:
Fundamental company valuation:Virpax Pharmaceuticals (VRPX)
Mass-produced product of Virpax Pharmaceuticals

Virpax Pharmaceuticals focuses on the preclinical development of analgesics, relying on government grants. By analyzing the rolling net income per share, an investor can see the final financial result for the year. This metric is calculated by dividing total net income by the total number of issued shares. This indicator allows for an assessment of the real return on each asset, excluding accounting distortions. The stability of this figure confirms the resilience of the company's capital.